Effect of cisplatin-metformin drug combination on GSTP1 mediated apoptosis

Date

2017-09-08

Author

Durukan, Özlem
Arslan, Şevki
Adalı, Orhan

Metadata

Show full item record

Item Usage Stats

120
views

0
downloads

Kllng cancer cells by trggerng cellular apoptoss seems to be the prevalent acton mechansm for cancer drugs. Usng substances that targetng the enzymes partcpatng n the apoptotc pathways that trggers the cellular apoptoss can be a useful treatment opton for cancer. GSTP enzyme, ts newly known role as a modulator of cellular survval and death, can be a good proten molecule for cancer studes. Although, csplatn as one of the most potent alkylatng agent that appled wth success n vast majorty of cancers, ts sde effects are stll lmts the usage of ths drug. Concordantly, to overcome the sde effects, producng less toxc and more effectve drug, combnaton treatment optons are popular research topc n recent years. Metformn s one of the natural product used for dabetes. Recent studes showed that metformn can reduce the rsk of gettng cancer even be able to treat t. In ths respect, the am of ths study s to determne the effects of metformn alone and combnaton wth csplatn on apoptoss n androgen ndependent prostate cancer cell lne (PC3). For ths purpose, cells were treated wth ether metformn alone n the range of 1–10 mM, csplatn alone or a combnaton of these two drugs. Cytotoxcty of drugs were determned wth Alamar Blue Assay and IC50 was calculated. The effect of drugs on proten expresson level of GSTP1 was determned by Western blot technque. In order to valdate our results, apoptoss was examned by usng Annexn V-EGFP kt (BoVson Incorporated CA., USA). Csplatn IC50 value was calculated as 30μM for PC3 cell lne. Both alone or combnaton of drugs were nhbted the prolferaton of PC3 cells n a concentraton dependent manner. GSTP1 proten expressons were sgnficantly down regulated (p=0.05) n metformn/csplatn treated cells compared to control groups. In addton to ths, Annexn V-EGFP levels whch was a sgn of apoptoss, were sgnficantly ncreased by drug combnaton. Ths study suggest that metformn and/or csplatn combnaton may decrease the tumour promoton as well as ncrease the apoptoss n PC3 cells. As a result, ths drug combnaton can be usable for treatment for prostate cancer.

Subject Keywords

Prostate cancer, Csplatn, Metformn, Apoptoss, GSTP1

URI

https://hdl.handle.net/11511/88246
http://molbioturk.org/molbiyokon17/img/abstract_book.pdf

Conference Name

The 5th Internatonal Congress of the Molecular Bology Assocaton of Turkey (MolByoKon’17), 8 - 10 September 2017

Collections

Department of Biology, Conference / Seminar

Suggestions

OpenMETU
Core

Effects of novel compound derived from vitamin e on prostate cancer cell line Ergen, Nuri; Severcan, Feride; Department of Biology (2016) Cancer is a complex disease characterized by uncontrolled cell proliferation, invasion and metastasis. It is known that vitamins having high antioxidant capacity, like vitamin A, C and E, play important roles in adjuvant therapy and as cancer protective agents. Vitamin E is a group of fat soluble antioxidant nutrients consisting of tocopherols and tocotrienols. Various research has been performed on the utility of vitamin E derivatives on cancer treatment. Energy metabolism of cells alters during cancer pro...
Effect of gemcitabine and retinoic acid loaded PAMAM dendrimer-coated magnetic nanoparticles on pancreatic cancer and stellate cell lines Yalcin, Serap; Erkan, Mert; Unsoy, Gozde; Parsian, Maryam; Kleeff, Jorg; Gündüz, Ufuk (2014-07-01) Gemcitabine is an anticancer drug used in the treatment of different cancer types, including pancreatic ductal adenocarcinoma. The maximum tolerated dose in humans is restricted by its side effects on healty cells. Furthermore, the fibrotic stroma produced by the pancreatic stellate cells prevents effective delivery of chemotherapeutic agents providing a safe-haven for the cancer cells. This becomes more of a problem considering the short half-life of this drug. Magnetic nanoparticle-based targeted drug del...
Role of ABCB1 and ABCC1 Gene Induction on Survival in Locally Advanced Breast Cancer Atalay, C.; DEMİRKAZIK, AHMET; Gündüz, Ufuk (2008-12-01) Drug resistance to chemotherapy in patients with locally advanced breast cancer results in a decrease in treatment efficacy and in patient survival. This study aimed to evaluate the impact of ABCB1 and ABCC1 gene induction during chemotherapy on disease-free and overall survival of breast cancer patients.
Synthesis of poly (dl-lactic-co-glycolic acid) coated magnetic nanoparticles for anti-cancer drug delivery Tansık, Gülistan; Gündüz, Ufuk; Department of Biology (2012) One of the main problems of current cancer chemotherapy is the lack of selectivity of anti-cancer drugs to tumor cells which leads to systemic toxicity and adverse side effects. In order to overcome these limitations, researches on controlled drug delivery systems have gained much attention. Nanoscale based drug delivery systems provide tumor targeting. Among many types of nanocarriers, superparamagnetic nanoparticles with their biocompatible polymer coatings can be targeted to an intented site by an extern...
Interplay between 15-lipoxygenase-1 and metastasis-associated antigen 1 in the metastatic potential of colorectal cancer Tuncer, S.; ÇAĞATAY, SİBEL; Keskus, A. G.; Colakoglu, M.; KONU KARAKAYALI, ÖZLEN; Banerjee, Sreeparna (2016-08-01) ObjectivesMetastasis-associated antigen 1 (MTA1) is implicated in metastasis while 15-lipoxygenase-1 (15-LOX-1) reduces cell motility, when re-expressed in colorectal cancer (CRC). We aimed to understand any potential interplay between MTA1 and 15-LOX-1 in CRC metastasis.

Citation Formats

Ö. Durukan, Ş. Arslan, and O. Adalı, “Effect of cisplatin-metformin drug combination on GSTP1 mediated apoptosis,” Istanbul, Turkey, 2017, p. 95, Accessed: 00, 2021. [Online]. Available: https://hdl.handle.net/11511/88246.